Amicus Therapeutics Quote - 0HF9

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

15.75

Bid

0.00

Offer

0.00

Volume

1,183

0.00 Day's Range 0.00

15.75 52 Week Range 15.75

Market Cap

4.706B

Previous Close

15.75

Open

Last Trade

6.835

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

537

Shares Outstanding

298,806,000

Dividend Yield

PE Ratio

-36.26

Earnings Per Share (EPS)

-0.19

Revenue

528.3M

Net Profit

-56.11M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.amicusrx.com

Headquarters

Wilmington, Delaware, USA

Founded

Amicus Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0HF9. The last closing price for Amicus Therapeutics was US$15.75. Over the last year, Amicus Therapeutics shares have traded in a share price range of US$ 15.75 to US$ 15.75.

Amicus Therapeutics currently has 298,806,000 shares in issue. The market capitalisation of Amicus Therapeutics is US$4.71 billion. Amicus Therapeutics has a price to earnings ratio (PE ratio) of -36.26.

No news to show yet.

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	15.75	15.75	15.75	532	15.75	DE
4	15.75	15.75	15.75	411	15.75	DE
12	15.75	15.75	15.75	537	15.75	DE
26	15.75	15.75	15.75	1673	15.75	DE
52	15.75	15.75	15.75	1135	15.75	DE
156	15.75	15.75	15.75	825	15.75	DE
260	15.75	15.75	15.75	677	15.75	DE

0HF9 - Frequently Asked Questions (FAQ)

What is the current Amicus Therapeutics share price?

The current share price of Amicus Therapeutics is US$ 15.75

How many Amicus Therapeutics shares are in issue?

Amicus Therapeutics has 298,806,000 shares in issue

What is the market cap of Amicus Therapeutics?

The market capitalisation of Amicus Therapeutics is USD 4.71B

What is the 1 year trading range for Amicus Therapeutics share price?

Amicus Therapeutics has traded in the range of US$ 15.75 to US$ 15.75 during the past year

What is the PE ratio of Amicus Therapeutics?

The price to earnings ratio of Amicus Therapeutics is -36.26

What is the cash to sales ratio of Amicus Therapeutics?

The cash to sales ratio of Amicus Therapeutics is 3.85

What is the reporting currency for Amicus Therapeutics?

Amicus Therapeutics reports financial results in USD

What is the latest annual turnover for Amicus Therapeutics?

The latest annual turnover of Amicus Therapeutics is USD 528.3M

What is the latest annual profit for Amicus Therapeutics?

The latest annual profit of Amicus Therapeutics is USD -56.11M

What is the registered address of Amicus Therapeutics?

The registered address for Amicus Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Amicus Therapeutics website address?

The website address for Amicus Therapeutics is www.amicusrx.com

Which industry sector does Amicus Therapeutics operate in?

Amicus Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LLAILunglife Ai Inc	3.00p (233.33%)	9.57M
CTAICatenai Plc	0.285p (83.87%)	450.76M
ALBAAlba Mineral Resources	0.0315p (65.79%)	685.89M
CLCOCloudcoco Group Plc	0.125p (47.06%)	7.13M
MODER8 Capital Investments Plc	1.60p (45.45%)	23.61M
TERNTern Plc	1.125p (-22.41%)	3.54M
IOMIomart Group Plc	27.00p (-14.56%)	1.14M
STXShield Therapeutics Plc	2.30p (-13.21%)	9.37M
NTQEnteq Technologies Plc	1.50p (-11.76%)	1.21M
VRCIVerici Dx Plc	1.875p (-11.76%)	418.93k
CHPCaledonian Holdings Plc	0.0025p (0.00%)	3.96B
ALBAAlba Mineral Resources	0.0315p (65.79%)	685.89M
CTAICatenai Plc	0.285p (83.87%)	450.76M
CPAICapai Plc	0.455p (2.25%)	394.69M
ORCPOracle Power Plc	0.0235p (-2.08%)	292.2M